Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma ; volume:5 ; number:1 ; day:15 ; month:5 ; year:2017 ; pages:1-3 ; date:12.2017
Acta Neuropathologica Communications ; 5, Heft 1 (15.5.2017), 1-3, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
López, Giselle
- Contributor
-
Oberheim Bush, Nancy Ann
Berger, Mitchel S.
Perry, Arie
Solomon, David A.
SpringerLink (Online service)
- DOI
-
10.1186/s40478-017-0440-x
- URN
-
urn:nbn:de:1111-201705254396
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- López, Giselle
- Oberheim Bush, Nancy Ann
- Berger, Mitchel S.
- Perry, Arie
- Solomon, David A.
- SpringerLink (Online service)
Other Objects (12)
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant